-
-
-
-
-
TOLD. YOU. SO.
-
Memorial Day weekend is becoming a BUST as most are still either locked down or partially opened. People not traveling via planes and resorts opening early are NOT seeing demand back... 50% vacancy rates on the most popular weekend of the year. To add insult to injury COVID-19 rates are INCREASING globally and even bumping up measurably in the U.S.... most of this is NOT priced in yet... do NOT over invest in this market folks, be ready for a second correct later this summer. And it could be a very painful one. $DJI ^DJI $SPY $TQQQ $BA $BAC $UPRO $XLE $ACES $TAN
-
Memorial Day weekend is becoming a BUST as most are still either locked down or partially opened. People not traveling via planes and resorts opening early are NOT seeing demand back... 50% vacancy rates on the most popular weekend of the year. To add insult to injury COVID-19 rates are INCREASING globally and even bumping up measurably in the U.S.... most of this is NOT priced in yet... do NOT over invest in this market folks, be ready for a second correct later this summer. And it could be a very painful one. $DJI ^DJI $SPY $TQQQ $BA $BAC $UPRO $XLE $ACES $TAN
-
$SAVA - A second opinion
*
If you have been following Cassava and their Alzheimers drug PTI-125, you will know that 1 of 2 trial endpoints was not recently met, sending the stock down almost 80%. But, I think the exodus was premature. Here is why:Per the companys press release, one endpoint WAS MET:
A secondary endpoint of CSF levels of IL1-beta, a core biomarker of neuroinflammation from baseline to day 28, was met, Cassava said. The drug was also found to be safe and well-tolerated.Per NIH, neuro inflammation is the CORE issue with Alzheimers:
Inflammation in Alzheimer's disease (AD) has emerged as a central pathology that likely plays a role in onset and progression of the disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214864/Cycling back to Cassavas press release, they state:
CSF levels of IL1-beta, a core biomarker of neuroinflammation ... was met
To reiterate the NIH definition, Neuro Inflammation is core to the onset and progression of Alzheimers. At some point, Cassava IS going to cycle back around to the secondary endpoint (neuro inflammation), and realize that ALONE constitutes an ALZHEIMER DRUG THAT WORKS.
In this case, traders were SO tuned into the word miss that they MISSED something EXTREMELY IMPORTANT -> The efficacy of PTI-125 towards Neuro Inflammation, in Alzheimers (ALONE), makes it A BLOCKBUSTER DRUG!
-
-
TOLD. YOU. SO.
-
Pi is a new digital currency developed by Stanford PhDs, with over 3.5 million members worldwide. To claim your Pi, follow this link https://minepi.com/geniusondrugs and use my username (geniusondrugs) as your invitation code.
-
-
TOLD. YOU. SO. !!!!
-
Looks like futures aren’t up, dude!
-
Hahah great end of speech . So Donald $SPY $SPX
-
-
Saben que , por qué no se meten este Mercado y los demás bien en el ojete todos . $SPY $SPX
-
-
-
@Chris Maybe they can announce another half a dozen Fortune 500 companies laying off 10 to 20,000 more jobs in total so that "the market" can rally another 500 points on Monday!! #Pumpdemic #completeBSmarket #correctionnear